Trade War Fallout Prompts San Diego's Illumina to Lower Outlook, Cut $100 Million in Costs
The San Diego-based company said it now expects 2025 adjusted profit ... China announced a ban on imports of genetic ...
Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Illumina recorta plantilla en su sede de San Diego
La empresa local de secuenciación genética citó ahorros de costos para alinearse con su futura estrategia comercial.
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.
Illumina addresses recent developments in China
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...
China Targets San Diego Biotech Firm in Broadening Blacklist
In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...
As Trump’s New Tariffs Begin, China Retaliates Against San Diego’s Illumina
China announced a ban on Tuesday on imports of genetic sequencers from San Diego medical equipment maker Illumina, just minutes after U.S. President Donald Trump's additional 10% tariff on Chinese ...
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...
Times of San Diego6d
Trade War Fallout Prompts San Diego’s Illumina to Lower Outlook, Cut $100 Million in Costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments. The San Diego-based ...
Wall Street Journal6d
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...
Morningstar7d
Illumina addresses recent developments in China
SAN DIEGO, March 10, 2025 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM ...